PMID- 35653618 OWN - NLM STAT- MEDLINE DCOM- 20220802 LR - 20220816 IS - 1743-5404 (Electronic) IS - 1743-5390 (Linking) VI - 16 IP - 3 DP - 2022 Apr TI - PM(2.5) induce the defective efferocytosis and promote atherosclerosis via HIF-1alpha activation in macrophage. PG - 290-309 LID - 10.1080/17435390.2022.2083995 [doi] AB - Epidemiological studies demonstrate that fine particulate matter (PM(2.5)) promotes the development of atherosclerosis. However, the mechanism insight of PM(2.5)-induced atherosclerosis is still lacking. The aim of this study was to explore the biological effects of hypoxia-inducible factor 1alpha (HIF-1alpha) on PM(2.5)-triggered atherosclerosis. The vascular stiffness, carotid intima-media thickness (CIMT), lipid and atherosclerotic lesion were increased when von Hippel-Lindau (VHL)-null mice were exposed to PM(2.5). Yet, knockout of HIF-1alpha markedly decreased the PM(2.5)-triggered atherosclerotic lesion. We firstly performed microarray analysis in PM(2.5)-treated bone morrow-derived macrophages (BMDMs), which showed that PM(2.5) significantly changed the genes expression patterns and affected biological processes such as phagocytosis, apoptotic cell clearance, cellular response to hypoxia, apoptotic process and inflammatory response. Moreover, the data showed knockout of HIF-1alpha remarkably relieved PM(2.5)-induced defective efferocytosis. Mechanistically, PM(2.5) inhibited the level of genes and proteins of efferocytosis receptor c-Mer tyrosine kinase (MerTK), especially in VHL-null BMDMs. In addition, PM(2.5) increased the genes and proteins of a disintegrin and metallopeptidase domain 17 (ADAM17), which caused the MerTK cleavage to form soluble MerTK (sMer) in plasma and cellular supernatant. The sMer was significantly up-regulated in plasma of VHL-null PM(2.5)-exposed mice. Moreover, PM(2.5) could induce defective efferocytosis and activate inflammatory response through MerTK/IFNAR1/STAT1 signaling pathway in macrophages. Our results demonstrate that PM(2.5) could induce defective efferocytosis and inflammation by activating HIF-1alpha in macrophages, ultimately resulting in accelerating atherosclerotic lesion formation and development. Our data suggest HIF-1alpha in macrophages might be a potential target for PM(2.5)-related atherosclerosis. FAU - Liang, Shuang AU - Liang S AD - Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, P.R. China. AD - Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, P.R. China. FAU - Sun, Qinglin AU - Sun Q AD - Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, P.R. China. AD - Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, P.R. China. FAU - Du, Zhou AU - Du Z AD - Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, P.R. China. AD - Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, P.R. China. FAU - Ren, Xiaoke AU - Ren X AD - Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, P.R. China. AD - Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, P.R. China. FAU - Xu, Qing AU - Xu Q AD - Core Facility Centre, Capital Medical University, Beijing, P.R. China. FAU - Sun, Zhiwei AU - Sun Z AD - Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, P.R. China. AD - Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, P.R. China. FAU - Duan, Junchao AU - Duan J AD - Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, P.R. China. AD - Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, P.R. China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220602 PL - England TA - Nanotoxicology JT - Nanotoxicology JID - 101233132 RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Particulate Matter) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (c-Mer Tyrosine Kinase) SB - IM MH - Animals MH - *Atherosclerosis/chemically induced/metabolism MH - *Carotid Intima-Media Thickness MH - Hypoxia/metabolism/pathology MH - Hypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolism MH - Macrophages MH - Mice MH - Particulate Matter/toxicity MH - Phagocytosis MH - Receptor Protein-Tyrosine Kinases/genetics/metabolism/pharmacology MH - c-Mer Tyrosine Kinase/metabolism OTO - NOTNLM OT - Atherosclerosis OT - Bone morrow-derived macrophage OT - Efferocytosis OT - HIF-1alpha OT - PM2.5 EDAT- 2022/06/03 06:00 MHDA- 2022/08/03 06:00 CRDT- 2022/06/02 15:42 PHST- 2022/06/03 06:00 [pubmed] PHST- 2022/08/03 06:00 [medline] PHST- 2022/06/02 15:42 [entrez] AID - 10.1080/17435390.2022.2083995 [doi] PST - ppublish SO - Nanotoxicology. 2022 Apr;16(3):290-309. doi: 10.1080/17435390.2022.2083995. Epub 2022 Jun 2.